Citation Tools
PDFRegular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
494 OR502, a best-in-class anti-LILRB2 antibody that enhances both innate and adaptive anti-tumor immune responses
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 494 OR502, a best-in-class anti-LILRB2 antibody that enhances both innate and adaptive anti-tumor immune responses